Janna Manjelievskaia, PhD, MPH

Director, HEOR
Veradigm

Poster(s):

• (B-036) Timely Disease Surveillance: Can a Large National EHR Network be Used to Estimate National and State Prevalence of Obesity and Type 2 Diabetes?
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-035) Use of lipid lowering therapies (LLTs) among adults by type 2 diabetes (T2D) diagnosis, with discordant apolipoprotein B (apoB) and LDL-cholesterol (LDL-C) values using US real-world data
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET